Alterity Therapeutics Ltd banner

Alterity Therapeutics Ltd
F:PBN0

Watchlist Manager
Alterity Therapeutics Ltd Logo
Alterity Therapeutics Ltd
F:PBN0
Watchlist
Price: 3.755 EUR Market Closed
Market Cap: €32.8m

Wall St Price Targets

PBN0 Price Targets Summary
Alterity Therapeutics Ltd

Wall Street analysts forecast PBN0 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBN0 is 7.277 EUR with a low forecast of 7.206 EUR and a high forecast of 7.491 EUR.

Lowest Forecast
Price Target
7.206 EUR
92% Upside
Average Forecast
Price Target
7.277 EUR
94% Upside
Highest Forecast
Price Target
7.491 EUR
100% Upside
Alterity Therapeutics Ltd Competitors:
Price Targets
QXO
SilverSun Technologies Inc
117% Upside
PTEN
Patterson-UTI Energy Inc
13% Upside
NN
NextNav Inc
110% Upside

Revenue
Forecast

7% / Year
Past Growth
147% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
147% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 147%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Alterity Therapeutics Ltd

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PBN0's stock price target?
Price Target
7.277 EUR

According to Wall Street analysts, the average 1-year price target for PBN0 is 7.277 EUR with a low forecast of 7.206 EUR and a high forecast of 7.491 EUR.

What is the Revenue forecast for Alterity Therapeutics Ltd?
Projected CAGR
147%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 147%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett